303 related articles for article (PubMed ID: 23874205)
1. Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis.
Novais FO; Carvalho LP; Graff JW; Beiting DP; Ruthel G; Roos DS; Betts MR; Goldschmidt MH; Wilson ME; de Oliveira CI; Scott P
PLoS Pathog; 2013; 9(7):e1003504. PubMed ID: 23874205
[TBL] [Abstract][Full Text] [Related]
2. Compartmentalized cytotoxic immune response leads to distinct pathogenic roles of natural killer and senescent CD8
Covre LP; Devine OP; Garcia de Moura R; Vukmanovic-Stejic M; Dietze R; Ribeiro-Rodrigues R; Guedes HLM; Lubiana Zanotti R; Falqueto A; Akbar AN; Gomes DCO
Immunology; 2020 Apr; 159(4):429-440. PubMed ID: 31925782
[TBL] [Abstract][Full Text] [Related]
3. Ageing dangerously; homing of senescent CD8 T cells in cutaneous Leishmaniasis.
Milling S
Immunology; 2020 Apr; 159(4):355-356. PubMed ID: 32182636
[TBL] [Abstract][Full Text] [Related]
4. Granzyme B Inhibition by Tofacitinib Blocks the Pathology Induced by CD8 T Cells in Cutaneous Leishmaniasis.
Novais FO; Nguyen BT; Scott P
J Invest Dermatol; 2021 Mar; 141(3):575-585. PubMed ID: 32738245
[TBL] [Abstract][Full Text] [Related]
5. CD8(+) granzyme B(+)-mediated tissue injury vs. CD4(+)IFNγ(+)-mediated parasite killing in human cutaneous leishmaniasis.
Santos Cda S; Boaventura V; Ribeiro Cardoso C; Tavares N; Lordelo MJ; Noronha A; Costa J; Borges VM; de Oliveira CI; Van Weyenbergh J; Barral A; Barral-Netto M; Brodskyn CI
J Invest Dermatol; 2013 Jun; 133(6):1533-40. PubMed ID: 23321919
[TBL] [Abstract][Full Text] [Related]
6. BALB/c mice infected with antimony treatment refractory isolate of Leishmania braziliensis present severe lesions due to IL-4 production.
Costa DL; Carregaro V; Lima-Júnior DS; Silva NM; Milanezi CM; Cardoso CR; Giudice Â; de Jesus AR; Carvalho EM; Almeida RP; Silva JS
PLoS Negl Trop Dis; 2011 Mar; 5(3):e965. PubMed ID: 21390155
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptors 2, 4, and 9 expressions over the entire clinical and immunopathological spectrum of American cutaneous leishmaniasis due to Leishmania(V.) braziliensis and Leishmania (L.) amazonensis.
Campos MB; Lima LVDR; de Lima ACS; Vasconcelos Dos Santos T; Ramos PKS; Gomes CMC; Silveira FT
PLoS One; 2018; 13(3):e0194383. PubMed ID: 29543867
[TBL] [Abstract][Full Text] [Related]
8. Protective and pathological functions of CD8+ T cells in Leishmania braziliensis infection.
Cardoso TM; Machado Á; Costa DL; Carvalho LP; Queiroz A; Machado P; Scott P; Carvalho EM; Bacellar O
Infect Immun; 2015 Mar; 83(3):898-906. PubMed ID: 25534940
[TBL] [Abstract][Full Text] [Related]
9. Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice.
Rocha FJ; Schleicher U; Mattner J; Alber G; Bogdan C
Infect Immun; 2007 Aug; 75(8):3823-32. PubMed ID: 17517868
[TBL] [Abstract][Full Text] [Related]
10. CD3
Ferraz R; Cunha CF; Pimentel MIF; Lyra MR; Pereira-Da-Silva T; Schubach AO; Da-Cruz AM; Bertho AL
Parasit Vectors; 2017 May; 10(1):219. PubMed ID: 28468680
[TBL] [Abstract][Full Text] [Related]
11. CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1β production.
Novais FO; Carvalho AM; Clark ML; Carvalho LP; Beiting DP; Brodsky IE; Carvalho EM; Scott P
PLoS Pathog; 2017 Feb; 13(2):e1006196. PubMed ID: 28192528
[TBL] [Abstract][Full Text] [Related]
12. IL-32γ promotes the healing of murine cutaneous lesions caused by Leishmania braziliensis infection in contrast to Leishmania amazonensis.
Gomes RS; Silva MVT; Dos Santos JC; de Lima Silva LL; Batista AC; Machado JR; Teixeira MM; Dorta ML; de Oliveira MAP; Dinarello CA; Joosten LAB; Ribeiro-Dias F
Parasit Vectors; 2017 Jul; 10(1):336. PubMed ID: 28709468
[TBL] [Abstract][Full Text] [Related]
13. Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis.
de Moura TR; Novais FO; Oliveira F; Clarêncio J; Noronha A; Barral A; Brodskyn C; de Oliveira CI
Infect Immun; 2005 Sep; 73(9):5827-34. PubMed ID: 16113301
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomic landscape of skin lesions in cutaneous leishmaniasis reveals a strong CD8
Fantecelle CH; Covre LP; Garcia de Moura R; Guedes HLM; Amorim CF; Scott P; Mosser D; Falqueto A; Akbar AN; Gomes DCO
Immunology; 2021 Dec; 164(4):754-765. PubMed ID: 34432883
[TBL] [Abstract][Full Text] [Related]
15. Contribution of Leishmania braziliensis antigen-specific CD4+ T, CD8+ T, NK and CD3+CD56+NKT cells in the immunopathogenesis of cutaneous leishmaniasis patients: Cytotoxic, activation and exhaustion profiles.
Cunha CF; Ferraz-Nogueira R; Costa VFA; Pimentel MIF; Chometon TQ; Lyra MR; Schubach AO; Da-Cruz AM; Bertho AL
PLoS One; 2020; 15(3):e0229400. PubMed ID: 32203546
[TBL] [Abstract][Full Text] [Related]
16. Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.
Salay G; Dorta ML; Santos NM; Mortara RA; Brodskyn C; Oliveira CI; Barbiéri CL; Rodrigues MM
Clin Vaccine Immunol; 2007 Sep; 14(9):1173-81. PubMed ID: 17626159
[TBL] [Abstract][Full Text] [Related]
17. Circulating Senescent T Cells Are Linked to Systemic Inflammation and Lesion Size During Human Cutaneous Leishmaniasis.
Covre LP; Martins RF; Devine OP; Chambers ES; Vukmanovic-Stejic M; Silva JA; Dietze R; Rodrigues RR; de Matos Guedes HL; Falqueto A; Akbar AN; Gomes DCO
Front Immunol; 2018; 9():3001. PubMed ID: 30662437
[No Abstract] [Full Text] [Related]
18. Immunopathological characterization of human cutaneous leishmaniasis lesions caused by Leishmania (Viannia) spp. in Amazonian Brazil.
Castro Gomes CM; Sousa MGT; Menezes JPB; Batista MC; Lima ACS; Belda W; Bradshaw D; Gama MEA; Laurenti MD; Silveira FT; Corbett CEP
Parasitol Res; 2017 May; 116(5):1423-1431. PubMed ID: 28224222
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic activity in cutaneous leishmaniasis.
Campos TM; Costa R; Passos S; Carvalho LP
Mem Inst Oswaldo Cruz; 2017 Nov; 112(11):733-740. PubMed ID: 29091132
[TBL] [Abstract][Full Text] [Related]
20. Impaired Th1 Response Is Associated With Therapeutic Failure in Patients With Cutaneous Leishmaniasis Caused by Leishmania braziliensis.
Carvalho AM; Guimarães LH; Costa R; Saldanha MG; Prates I; Carvalho LP; Arruda S; Carvalho EM
J Infect Dis; 2021 Feb; 223(3):527-535. PubMed ID: 32620011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
